Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1074

1.

Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Omae K, Kodera Y.

Ann Surg Oncol. 2019 Jun 13. doi: 10.1245/s10434-019-07512-7. [Epub ahead of print]

PMID:
31197518
2.

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.

Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H.

Mol Ther Oncolytics. 2019 May 13;13:107-115. doi: 10.1016/j.omto.2019.04.004. eCollection 2019 Jun 28.

PMID:
31193737
3.

Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens.

Sonohara F, Yamada S, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.

Eur J Surg Oncol. 2019 May 22. pii: S0748-7983(19)30457-3. doi: 10.1016/j.ejso.2019.05.019. [Epub ahead of print]

PMID:
31147087
4.

Preoperative six-minute walk distance as a predictor of postoperative complication in patients with esophageal cancer.

Inoue T, Ito S, Kanda M, Niwa Y, Nagaya M, Nishida Y, Hasegawa Y, Koike M, Kodera Y.

Dis Esophagus. 2019 May 20. pii: doz050. doi: 10.1093/dote/doz050. [Epub ahead of print]

PMID:
31111872
5.

A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey.

Poudel S, Hirano S, Kurashima Y, Stefanidis D, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hashimoto D, Hida K, Izaki T, Iwase H, Kawamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Kodera Y.

Surg Today. 2019 May 17. doi: 10.1007/s00595-019-01819-4. [Epub ahead of print]

PMID:
31102022
6.

Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015.

Iida M, Kodera Y, Dodds A, Ho AYL, Nivison-Smith I, Akter MR, Wu T, Lie AKW, Ghavamzadeh A, Kang HJ, Ong TC, Gyi AA, Farzana T, Baylon H, Gooneratne L, Tang JL, Bunworasate U, Huynh VM, Srivastava A, Okamoto S, Atsuta Y; Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT).

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0554-9. [Epub ahead of print]

PMID:
31089289
7.

A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.

Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0542-0. [Epub ahead of print] No abstract available.

PMID:
31089273
8.

Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study.

Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y.

Asian J Endosc Surg. 2019 May 8. doi: 10.1111/ases.12710. [Epub ahead of print]

PMID:
31070004
9.

Identification of plasma binding proteins for glucose-dependent insulinotropic polypeptide.

Hoshiyama A, Fujimoto K, Konno R, Sasaki S, Momozono A, Kodera Y, Shichiri M.

Endocr J. 2019 Apr 26. doi: 10.1507/endocrj.EJ18-0472. [Epub ahead of print]

10.

The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.

Nakanishi K, Kanda M, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Kodera Y.

Gastric Cancer. 2019 May 4. doi: 10.1007/s10120-019-00967-3. [Epub ahead of print]

PMID:
31055693
11.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30235-6. doi: 10.1016/j.bbmt.2019.04.012. [Epub ahead of print] Review.

PMID:
31002990
12.

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.

Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Gastrointest Oncol. 2019 Jan 15;11(1):17-27. doi: 10.4251/wjgo.v11.i1.17.

13.

Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset.

Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Gastric Cancer. 2019 Apr 6. doi: 10.1007/s10120-019-00961-9. [Epub ahead of print]

PMID:
30955110
14.

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.

Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M.

J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.

PMID:
30925125
15.

Effects of duration of initial treatment on postoperative complications in pancreatic cancer.

Yamada S, Takami H, Sonohara F, Hayashi M, Fujii T, Kodera Y.

J Hepatobiliary Pancreat Sci. 2019 Jun;26(6):235-241. doi: 10.1002/jhbp.622. Epub 2019 Apr 9.

PMID:
30919565
16.

Detection of a novel tick-borne flavivirus and its serological surveillance.

Shimoda H, Hayasaka D, Yoshii K, Yokoyama M, Suzuki K, Kodera Y, Takeda T, Mizuno J, Noguchi K, Yonemitsu K, Minami S, Kuwata R, Takano A, Maeda K.

Ticks Tick Borne Dis. 2019 Jun;10(4):742-748. doi: 10.1016/j.ttbdis.2019.03.006. Epub 2019 Mar 16.

PMID:
30902589
17.

Positive rates of anti-acari-borne disease antibodies of rural inhabitants in Japan.

Takeda T, Fujita H, Iwasaki M, Kasai M, Tatori N, Endo T, Kodera Y, Yamabata N.

J Vet Med Sci. 2019 May 31;81(5):758-763. doi: 10.1292/jvms.18-0572. Epub 2019 Mar 20.

18.

The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset.

Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Dig Surg. 2019 Mar 6:1-10. doi: 10.1159/000497454. [Epub ahead of print]

PMID:
30840952
19.

Gain in polycrystalline Nd-doped alumina: leveraging length scales to create a new class of high-energy, short pulse, tunable laser materials.

Penilla EH, Devia-Cruz LF, Duarte MA, Hardin CL, Kodera Y, Garay JE.

Light Sci Appl. 2018 Jul 4;7:33. doi: 10.1038/s41377-018-0023-z. eCollection 2018.

20.

Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.

Tsutsuyama M, Nakanishi H, Yoshimura M, Oshiro T, Kinoshita T, Komori K, Shimizu Y, Ichinosawa Y, Kinuta S, Wajima K, Sakakibara Y, Yatabe Y, Ito S, Kodera Y.

PLoS One. 2019 Feb 27;14(2):e0212221. doi: 10.1371/journal.pone.0212221. eCollection 2019.

21.

"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries".

Aljurf M, Weisdorf D, Alfraih F, Szer J, Müller C, Confer D, Hashmi S, Kröger N, Shaw BE, Greinix H, Kharfan-Dabaja MA, Foeken L, Seber A, Ahmed S, El-Jawahri A, Al-Awwami M, Atsuta Y, Pasquini M, Hanbali A, Alzahrani H, Okamoto S, Gluckman E, Mohty M, Kodera Y, Horowitz M, Niederwieser D, El Fakih R.

Bone Marrow Transplant. 2019 Feb 18. doi: 10.1038/s41409-019-0476-6. [Epub ahead of print] Review.

PMID:
30778127
22.

Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.

Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y.

HPB (Oxford). 2019 Feb 14. pii: S1365-182X(19)30067-X. doi: 10.1016/j.hpb.2019.01.012. [Epub ahead of print]

PMID:
30773450
23.

A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.

Izumi D, Gao F, Toden S, Sonohara F, Kanda M, Ishimoto T, Kodera Y, Wang X, Baba H, Goel A.

EBioMedicine. 2019 Mar;41:268-275. doi: 10.1016/j.ebiom.2019.01.057. Epub 2019 Feb 13.

24.

Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis.

Iizuka A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Feb 8. doi: 10.1007/s00268-019-04942-y. [Epub ahead of print]

PMID:
30737551
25.

Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma.

Sonohara F, Yamada S, Tanaka N, Suenaga M, Takami H, Hayashi M, Niwa Y, Sugimoto H, Hattori N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Ann Gastroenterol Surg. 2018 Sep 27;3(1):65-74. doi: 10.1002/ags3.12212. eCollection 2019 Jan.

26.

Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.

Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y.

Ann Surg Oncol. 2019 May;26(5):1535-1543. doi: 10.1245/s10434-019-07166-5. Epub 2019 Jan 23.

PMID:
30673899
27.

[Looking Back on the 10th Anniversary of Radiological Physics and Technology(RPT)].

Doi K, Kodera Y, Sanada S, Shiraishi J, Saito S.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(1):1-12. doi: 10.6009/jjrt.2019_JSRT_75.1.1. Japanese. No abstract available.

28.

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.

Nomoto H, Takami A, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Morishita E.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E214. doi: 10.3390/ijms20010214.

29.

Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.

Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2019 Mar;26(3):836-844. doi: 10.1245/s10434-018-07149-y. Epub 2019 Jan 7.

PMID:
30617870
30.

Background factors influencing postgastrectomy syndromes after various types of gastrectomy.

Kinami S, Takahashi M, Urushihara T, Ikeda M, Yoshida M, Uenosono Y, Oshio A, Suzukamo Y, Terashima M, Kodera Y, Nakada K.

World J Clin Cases. 2018 Dec 26;6(16):1111-1120. doi: 10.12998/wjcc.v6.i16.1111.

31.

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.

Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

J Transl Med. 2019 Jan 3;17(1):1. doi: 10.1186/s12967-018-1762-6.

32.

CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.

Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K.

Anticancer Res. 2019 Jan;39(1):99-106. doi: 10.21873/anticanres.13084.

PMID:
30591445
33.

The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set.

Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Ann Surg Oncol. 2019 Feb;26(2):456-464. doi: 10.1245/s10434-018-07121-w. Epub 2018 Dec 18.

PMID:
30565044
34.

RASEF expression correlates with hormone receptor status in breast cancer.

Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Miwa T, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T.

Oncol Lett. 2018 Dec;16(6):7223-7230. doi: 10.3892/ol.2018.9542. Epub 2018 Oct 3.

35.

Surgical risk and benefits of laparoscopic surgery for elderly patients with gastric cancer: a multicenter prospective cohort study.

Honda M, Kumamaru H, Etoh T, Miyata H, Yamashita Y, Yoshida K, Kodera Y, Kakeji Y, Inomata M, Konno H, Seto Y, Kitano S, Watanabe M, Hiki N.

Gastric Cancer. 2019 Jul;22(4):845-852. doi: 10.1007/s10120-018-0898-7. Epub 2018 Dec 11.

PMID:
30539321
36.

Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.

Hayashi S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Gastric Cancer. 2019 Jul;22(4):853-863. doi: 10.1007/s10120-018-0902-2. Epub 2018 Nov 27.

PMID:
30483985
37.

Dual-center randomized clinical trial exploring the optimal duration of antimicrobial prophylaxis in patients undergoing pancreaticoduodenectomy following biliary drainage.

Yamamoto T, Satoi S, Fujii T, Yamada S, Yanagimoto H, Yamaki S, Takami H, Hirooka S, Kosaka H, Kotsuka M, Miyara T, Kodera Y.

Ann Gastroenterol Surg. 2018 Sep 17;2(6):442-450. doi: 10.1002/ags3.12209. eCollection 2018 Nov.

38.

Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.

Nakagawa N, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Cancer Med. 2018 Dec;7(12):6020-6029. doi: 10.1002/cam4.1868. Epub 2018 Nov 8.

39.

Long-term quality of life and nutrition status of the aboral pouch reconstruction after total gastrectomy for gastric cancer: a prospective multicenter observational study (CCOG1505).

Tanaka C, Kanda M, Murotani K, Yoshikawa T, Cho H, Ito Y, Matsui T, Nakayama H, Yamada T, Kobayashi D, Fujiwara M, Kodera Y.

Gastric Cancer. 2019 May;22(3):607-616. doi: 10.1007/s10120-018-0893-z. Epub 2018 Oct 31.

PMID:
30382468
40.

Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset.

Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Mar;43(3):870-877. doi: 10.1007/s00268-018-4834-0.

PMID:
30377722
41.

[The Know-how Useful for Publication of Your Article in RPT].

Shiraishi J, Nose H, Fujimoto K, Ohno T, Yamamoto T, Kanematsu N, Kodera Y, Hasegawa T, Araki F, Doi K, Kawamura S.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(10):1197-1206. doi: 10.6009/jjrt.2018_JSRT_74.10.1197. Japanese. No abstract available.

42.

Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.

Maeda H, Okada KI, Fujii T, Oba MS, Kawai M, Hirono S, Kodera Y, Sho M, Akahori T, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Sakamoto J, Yamaue H.

Oncol Lett. 2018 Nov;16(5):6847-6853. doi: 10.3892/ol.2018.9422. Epub 2018 Sep 7.

43.

Identification and full-genome characterization of novel circoviruses in masked palm civets (Paguma larvata).

Nishizawa T, Sugimoto Y, Takeda T, Kodera Y, Hatano Y, Takahashi M, Okamoto H.

Virus Res. 2018 Oct 15;258:50-54. doi: 10.1016/j.virusres.2018.10.004. Epub 2018 Oct 5.

PMID:
30296458
44.

Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification.

Morimoto D, Yamada S, Murotani K, Sonohara F, Takami H, Suenaga M, Hayashi M, Niwa Y, Tashiro M, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.

Pancreas. 2018 Nov/Dec;47(10):1350-1356. doi: 10.1097/MPA.0000000000001186.

PMID:
30286011
45.

Cutting-edge evidence of adjuvant treatments for gastric cancer.

Shimizu D, Kanda M, Kodera Y, Sakamoto J.

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1109-1122. doi: 10.1080/17474124.2018.1530985. Epub 2018 Oct 10.

PMID:
30274536
46.

Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.

Umeda S, Kanda M, Koike M, Tanaka H, Miwa T, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Kodera Y.

Oncol Rep. 2018 Dec;40(6):3772-3780. doi: 10.3892/or.2018.6742. Epub 2018 Sep 27.

PMID:
30272363
47.

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.

Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H.

Cancers (Basel). 2018 Sep 26;10(10). pii: E356. doi: 10.3390/cancers10100356. Review.

48.

Expression of sushi domain containing two reflects the malignant potential of gastric cancer.

Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y.

Cancer Med. 2018 Oct;7(10):5194-5204. doi: 10.1002/cam4.1793. Epub 2018 Sep 27.

49.

Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?

Kodera Y.

Ann Gastroenterol Surg. 2018 Jul 10;2(5):339-347. doi: 10.1002/ags3.12191. eCollection 2018 Sep. Review.

50.

Anti-inflammatory action of cysteine derivative S-1-propenylcysteine by inducing MyD88 degradation.

Suzuki JI, Kodera Y, Miki S, Ushijima M, Takashima M, Matsutomo T, Morihara N.

Sci Rep. 2018 Sep 20;8(1):14148. doi: 10.1038/s41598-018-32431-0.

Supplemental Content

Loading ...
Support Center